Lancet Infectious Diseases

New nomenclature for mpox (monkeypox) and monkeypox virus clades.  23:273-275. 2023

Infections caused by Clostridium perfringens and Paeniclostridium sordellii after unsafe abortion.  23:e48-e55. 2023

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.  22:401-412. 2022

The value of open-source clinical science in pandemic response: lessons from ISARIC.  21:1623-1624. 2021

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study.  21:1257-1270. 2021

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction.  20:e181-e191. 2020

Congenital viral infections continue to affect neonates.  20:152-153. 2020

Kissing, saliva exchange, and transmission of Neisseria gonorrhoeae.  19:e367-e369. 2019

Serocorrelates of protection against infant group B streptococcus disease.  19:e162-e171. 2019

Treatment recommendations for trichomoniasis in women.  19:20-21. 2019

Advancing the public health applications of Chlamydia trachomatis serology.  18:e399-e407. 2018

Global, regional, and national burden of tuberculosis, 1990-2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study.  18:1329-1349. 2018

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.  18:1191-1210. 2018

Intravascular abscess in Lemierre's syndrome due to meticillin-sensitive Staphylococcus aureus.  18:1287. 2018

Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.  18:1251-1259. 2018

Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.  18:573-581. 2018

The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.  18:261-284. 2018

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.  17:1255-1265. 2017

Sexually transmitted infections: challenges ahead.  17:e235-e279. 2017

Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.  17:e177-e188. 2017

Underestimate of annual malaria imports to Canada.  17:141-142. 2017

Should testing of donors be restricted to active Zika virus areas?.  16:1108-1109. 2016

Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis.  16:828-837. 2016

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects..  16:e47-e63. 2016

Corrections..  15:998. 2015

Predictions of geriatric HIV in 2030.  15:753-754. 2015

Middle East respiratory syndrome coronavirus in dromedary camels: An outbreak investigation.  14:140-145. 2014

Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, south Asia, and Latin America for 2012: A systematic review and meta-analysis.  14:731-741. 2014

Pre-exposure prophylaxis to intensify the fight against HIV.  14:443-445. 2014

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: A modelling study.  12:687-695. 2012

Use of hormonal contraceptives and risk of HIV-1 transmission - Authors' reply.  12:510-511. 2012

Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study.  12:19-26. 2012

Acute hepatitis C and HIV coinfection.  9:775-783. 2009

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.  8:477-489. 2008

HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS.  6:794-804. 2006

Clinical pharmacodynamics of HIV-1 protease inhibitors: Use of inhibitory quotients to optimise pharmacotherapy.  6:215-225. 2006

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.  5:361-373. 2005

Confronting the avian influenza threat: Vaccine development for a potential pandemic.  4:499-509. 2004

Prospects for an AIDS vaccine: Three big questions, no easy answers.  4:397-413. 2004

Is protection in HIV infection due to Bw4 or not to Bw4?.  1:221-222. 2001